THRIVENT FINANCIAL FOR LUTHERANS - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
THRIVENT FINANCIAL FOR LUTHERANS ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q2 2023$316
-30.7%
42,951
-2.4%
0.00%0.0%
Q1 2023$456
-15.2%
44,001
-3.4%
0.00%0.0%
Q4 2022$538
-99.9%
45,544
-0.7%
0.00%
-66.7%
Q3 2022$963,000
-29.4%
45,873
+4.4%
0.00%
-25.0%
Q2 2022$1,364,000
-14.8%
43,932
+12.7%
0.00%
+33.3%
Q1 2022$1,600,000
-55.4%
38,979
-52.7%
0.00%
-57.1%
Q4 2021$3,584,000
+472.5%
82,437
+559.9%
0.01%
+600.0%
Q3 2021$626,000
-17.8%
12,493
+3.3%
0.00%
-50.0%
Q2 2021$762,000
-31.9%
12,091
+0.4%
0.00%0.0%
Q1 2021$1,119,000
+5.9%
12,044
+2.1%
0.00%0.0%
Q4 2020$1,057,000
-15.6%
11,794
-2.7%
0.00%
-33.3%
Q3 2020$1,252,000
-57.6%
12,116
-67.5%
0.00%
-66.7%
Q2 2020$2,950,000
+38.6%
37,301
+1.4%
0.01%
+12.5%
Q1 2020$2,128,000
+12.9%
36,776
+5.3%
0.01%
+60.0%
Q4 2019$1,885,000
+3.5%
34,940
+0.3%
0.01%
-16.7%
Q3 2019$1,822,000
+6.7%
34,849
-1.4%
0.01%
+20.0%
Q2 2019$1,708,000
-1.2%
35,347
+3.3%
0.01%0.0%
Q1 2019$1,729,000
-7.7%
34,223
+8.3%
0.01%
-28.6%
Q4 2018$1,873,000
-5.2%
31,596
+5.3%
0.01%
+16.7%
Q3 2018$1,975,000
+61.2%
30,000
+23.6%
0.01%
+50.0%
Q2 2018$1,225,000
-1.4%
24,267
+2.8%
0.00%0.0%
Q1 2018$1,242,000
+22.6%
23,598
+8.3%
0.00%
+33.3%
Q4 2017$1,013,000
+17.2%
21,790
+2.0%
0.00%0.0%
Q3 2017$864,000
+21.5%
21,360
+1.9%
0.00%0.0%
Q2 2017$711,000
+25.2%
20,970
+7.2%
0.00%
+50.0%
Q1 2017$568,000
-56.7%
19,560
-51.0%
0.00%
-66.7%
Q4 2016$1,312,000
+6.5%
39,940
+2.2%
0.01%0.0%
Q3 2016$1,232,000
+187.9%
39,070
+156.7%
0.01%
+200.0%
Q2 2016$428,000
-16.4%
15,220
+8.1%
0.00%0.0%
Q1 2016$512,000
-1.2%
14,080
+8.7%
0.00%0.0%
Q4 2015$518,000
+44.7%
12,950
+3.2%
0.00%0.0%
Q3 2015$358,000
-6.3%
12,550
+8.2%
0.00%0.0%
Q2 2015$382,000
+22.0%
11,600
+6.4%
0.00%0.0%
Q1 2015$313,000
+6.5%
10,900
+0.9%
0.00%0.0%
Q4 2014$294,000
+30.1%
10,800
+1.9%
0.00%
+100.0%
Q3 2014$226,000
-7.0%
10,600
-1.9%
0.00%0.0%
Q2 2014$243,000
-9.0%
10,800
+2.4%
0.00%
-50.0%
Q1 2014$267,000
+10.8%
10,550
+0.5%
0.00%
+100.0%
Q4 2013$241,000
+23.0%
10,500
+1.9%
0.00%0.0%
Q3 2013$196,00010,3000.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 120,504$10,797,0004.20%
SNYDER CAPITAL MANAGEMENT L P 723,477$64,824,0002.12%
Hillcrest Asset Management LLC 161,428$14,464,0001.97%
RICE HALL JAMES & ASSOCIATES, LLC 587,727$52,660,0001.85%
PALISADE CAPITAL MANAGEMENT, LP 579,009$51,879,0001.33%
Pier Capital, LLC 109,786$9,837,0001.04%
Paradiem, LLC 21,320$2,286,0000.97%
EARNEST PARTNERS LLC 1,390,735$124,610,0000.86%
Ridgewood Investments LLC 10,004$1,034,0000.82%
Tygh Capital Management, Inc. 56,334$5,048,0000.78%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders